PB2097: ZANUBRUTINIB PLUS RITUXIMAB FOR THE TREATMENT OF ELDERLY UNFIT PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE-B CELL LYMPHOMA. (23rd June 2022) - Bai, J.-F.; Li, J. T.; Feng, R.; Qian, L.; Yin, J.; Liu, H.